1 week Ago By Defense World Staff
Bank of Montreal Can reduced its position in Profound Medical Corp. ( NASDAQ:PROF – Free Report ) by 17.9% during the fourth quarter, according to its most recent 13F filing with the SEC.
The firm owned 11,696 shares of the company’s stock after selling 2,551 shares during the period. Bank of Montreal Can’s holdings in Profound Medical were worth $88,000 as of its most recent SEC filing. Several other institutional investors have also added to or reduced their stakes in the business.
Gagnon Securities LLC lifted its stake in shares of Profound Medical by 12.6% during the 4th quarter. Gagnon Securities LLC now owns 1,652,531 shares of the company’s stock valued at $12,411,000 after buying an additional 185,284 shares in the last quarter.
Gagnon Advisors LLC boosted its holdings in shares of Profound Medical by 20.0% in the fourth quarter. Gagnon Advisors LLC now owns 896,671 shares of the company’s stock worth $6,734,000 after acquiring an additional 149,445 shares during the period.
MTM Investment Management LLC grew its position in shares of Profound Medical by 10.4% in the fourth quarter. MTM Investment Management LLC now owns 18,575 shares of the company’s stock valued at $139,000 after purchasing an additional 1,750 shares in the last quarter.
Truist Financial Corp bought a new stake in shares of Profound Medical during the 4th quarter valued at $376,000. Finally, Thompson Davis & CO. Inc.
lifted its holdings in Profound Medical by 78.9% during the 4th quarter. Thompson Davis & CO.
Inc. now owns 182,295 shares of the company’s stock worth $1,369,000 after purchasing an additional 80,395 shares in the last quarter. 47.
86% of the stock is owned by hedge funds and other institutional investors. Analysts Set New Price Targets Separately, Lake Street Capital lowered their price target on shares of Profound Medical from $17.00 to $11.
00 and set a “buy” rating on the stock in a report on Wednesday. Profound Medical Stock Up 0.8 % PROF opened at $4.
76 on Friday. The company has a debt-to-equity ratio of 0.11, a current ratio of 6.
12 and a quick ratio of 5.16. Profound Medical Corp.
has a one year low of $3.90 and a one year high of $11.42.
The firm has a market capitalization of $142.99 million, a P/E ratio of -3.55 and a beta of 0.
68. The company has a fifty day moving average price of $6.03 and a 200-day moving average price of $6.
92. Profound Medical ( NASDAQ:PROF – Get Free Report ) last announced its earnings results on Thursday, March 6th. The company reported ($0.
20) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.11.
The business had revenue of $4.18 million for the quarter, compared to analyst estimates of $5.92 million.
Profound Medical had a negative return on equity of 85.22% and a negative net margin of 349.41%.
Equities research analysts expect that Profound Medical Corp. will post -1.12 earnings per share for the current fiscal year.
Profound Medical Profile ( Free Report ) Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.
Further Reading Five stocks we like better than Profound Medical What Does a Stock Split Mean? Markets Think Robinhood Earnings Could Send the Stock Up How to Read Stock Charts for Beginners Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? 3 Grocery Stocks That Can Help Take a Bite Out of Inflation AT&T: Subscriber Growth & Buybacks Signal Bullish Turnaround Want to see what other hedge funds are holding PROF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Profound Medical Corp. ( NASDAQ:PROF – Free Report ).
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter ..
